IVI MEMBER SPOTLIGHT: The Alliance for Aging Research

In late January, we sat down with Michael Ward from of IVI's newest members, The Alliance for Aging Research. We are so pleased to partner with such a dynamic organization.       Thank you so much for speaking with us today. Could you tell us a little bit about the Alliance for Aging Research? [...]

2021-02-22T11:33:23-06:00February 22nd, 2021|Blog, IVI News, Member Spotlight|

Looking Ahead to 2021: Let’s Really Make 2021 the Year of the Patient

Author: Jennifer Bright, MPA, Executive Director, IVI The promise of a new year offers an opportunity to recall our best moments in 2020 (surely there are a few!) and get excited for what's ahead. For IVI, I've been thinking about the accomplishments not just in 2020, but in the three years since I joined this [...]

2020-12-23T11:29:46-06:00December 23rd, 2020|Blog|

IVI MEMBER SPOTLIGHT: Andrea Maresca, MPH

Earlier this fall, we sat down with Andrea Maresca, an IVI Board Member, who recently joined our organization. We are thrilled to have an expert in federal and state healthcare policy as part of our organization.       Tell us a little about your background and how you came to be connected with IVI. [...]

2020-12-10T14:14:24-06:00December 10th, 2020|Blog, IVI News, Member Spotlight|

IVI MEMBER SPOTLIGHT: Dr. Wayne Burton

For our first Member Spotlight, we chatted with Dr. Wayne Burton about what he sees as the future of value assessment. Dr. Burton has been with IVI almost since its inception. This interview is an adaptation of a conversation we had with Dr. Burton this fall.     Tell us a little about yourself and [...]

2020-12-10T11:27:11-06:00September 29th, 2020|Blog, IVI News, Member Spotlight|

Tackling Hard Questions in Value

Author: Jennifer Bright, MPA, Executive Director, IVI For decades, we've known that untreated or poorly treated Major Depressive Disorder (MDD) is an enormous burden on individual patients, our health care system, and our society. Despite having this knowledge, there is much work to do in order to support and optimize cost-effective care for patients suffering [...]

2020-12-29T17:01:00-06:00September 9th, 2020|Blog|

Exploring Patient Heterogeneity and Diversity in Treatment Responses

Author: Jennifer Bright, MPA Everyone hopes for a COVID vaccine so our lives can return to normal. Yet, we know that even if clinical trials prove a vaccine's effectiveness, our society will still have to endure a long process of distribution. I'm personally willing to wait for a vaccine for healthcare workers, the elderly, and [...]

2020-12-29T17:01:22-06:00August 20th, 2020|Blog|

How do we identify and measure value for patients with rare diseases?

Authors: Annie Kennedy and Joff Masukawa. Rare diseases impact 1 in 10 Americans, and over 400 million people worldwide. The current development and FDA approval process can cost hundreds of millions of dollars – and take an average of 15 years – to develop one therapy. For the 30% of children diagnosed with a rare [...]

2020-12-29T17:01:46-06:00July 22nd, 2020|Blog|

Measuring Value: COVID-19 Forces a Reassessment

Authors: Patricia Deverka, Jennifer Bright, Louis Garrison, Samuel Nussbaum We have seen the COVID-19 pandemic decimate people’s lives, health care systems, and the global and US economy, with investments by the US government exceeding $4 trillion dollars and with unemployment approaching 20%. In recent days, numerous articles have speculated on the pricing for Gilead’s new [...]

2020-12-29T17:02:53-06:00May 20th, 2020|Blog|
Go to Top